INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.41, sa.4, ss.773-776, 2009 (SCI-Expanded)
To identify a subgroup of normogonadotropic men who may benefit relatively more from TC (tamoxifen citrate; a widely prescribed drug for male infertility) among those with FSH (follicle-stimulating hormone) values in the lower or higher halves of the normal range.